Results of Preventive Chemotherapy of Tuberculosis in HIV-Infected Women of Reproductive Age in Nizhny Novgorod Region

Read full text Summarise with VIRAT
Authors: G. F. RUSАNOVSKАYA, I. A. Kas'yanova, Alexander S. Shprykov
Cited by: 0
References: 6

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

The objective: to analyze results of preventive chemotherapy of tuberculosis in HIV-infected women of the reproductive age. Subjects and Methods. The results of tuberculosis preventive chemotherapy were retrospectively analyzed in 675 HIV-positive women aged 18-44 years for 2015-2019 (continuous sampling). The comparison group consisted of 6018 HIV-infected female patients of the same age who received no preventive chemotherapy of tuberculosis during the analyzed period. Results. The average age of women receiving preventive chemotherapy of tuberculosis (PC TB+ Group) made 32.9±0.2 years. Isoniazid was well tolerated with the drug discontinued due to adverse events only in 11/675 (1.6±2.9%) women. Only 316/675 (46.8±3.6%) women completed the full 6-month course of preventive chemotherapy; the rest defaulted within the first 3 months. From PC TB+ Group, 19/675 (0.7±2.7%) patients developed tuberculosis within the next 5 years. Among 348 women who defaulted within the first 3 months, 17 (4.9±1.5%) developed tuberculosis. Conclusion. The obtained results prove the feasibility of preventive chemotherapy of tuberculosis in HIV-positive women of the reproductive age, as it reduces the incidence of tuberculosis in the following 5 years (19/675 (0.7±2.7% versus 447/6018 (7.4±2.7%) women who developed TB, OR = 2.77, CI (1.73-4.42)). Even though 46.8±3.6% of women defaulted from preventive chemotherapy within the first 3 months.

Fields of Study & Subjects

Tuberculosis Research and Epidemiology Infectious Diseases and Tuberculosis HIV/AIDS Research and Interventions

Publication details

Journal / source
Tuberculosis and lung diseases
Volume
104
Issue
1
Pages
20–25
Publication date
22 March 2026
Language
EN